If the kits are shipping out Tuesday and incellCEPT is for "CCR5 receptor occupancy," don't you also need Leronlimab? So is this foreshadowing Leronlimab approval on Tuesday? Doesn't make sense to release a test that relies on Leronlimab and it not being approved at the same time or shortly after.

"IncellKINE Kit is for 14 cytokines and chemokines that can also be used to diagnose and treat long haulers. The incellCEPT CCR5 RO Kit is for quantifying CCR5 and determining CCR5 receptor occupancy"

https://twitter.com/brucep13/status/1302337741728825345